Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model.

Hoskins P, Eccleston A, Hurry M, Dyer M.

Gynecol Oncol. 2019 Jan 28. pii: S0090-8258(19)30061-7. doi: 10.1016/j.ygyno.2019.01.018. [Epub ahead of print]

PMID:
30704745
2.

Vaccination Timeliness at Age 24 Months in Michigan Children Born 2006-2010.

Wagner AL, Eccleston AM, Potter RC, Swanson RG, Boulton ML.

Am J Prev Med. 2018 Jan;54(1):96-102. doi: 10.1016/j.amepre.2017.09.014.

PMID:
29254557
3.

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.

Eccleston A, Bentley A, Dyer M, Strydom A, Vereecken W, George A, Rahman N.

Value Health. 2017 Apr;20(4):567-576. doi: 10.1016/j.jval.2017.01.004. Epub 2017 Mar 3.

4.

The protein world.

Finkelstein J, Eccleston A, Shadan S.

Nature. 2016 Sep 15;537(7620):319. doi: 10.1038/537319a. No abstract available.

PMID:
27629637
5.

Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective.

Eccleston A, Bentley A, Dyer M, Vereecken W, George A, Rahman N.

Value Health. 2015 Nov;18(7):A361. doi: 10.1016/j.jval.2015.09.697. Epub 2015 Oct 20. No abstract available.

6.

Presenting the epigenome roadmap.

Skipper M, Eccleston A, Gray N, Heemels T, Le Bot N, Marte B, Weiss U.

Nature. 2015 Feb 19;518(7539):313. doi: 10.1038/518313a. No abstract available.

PMID:
25693561
7.

Frontiers in biology.

Eccleston A, Gray N, Shadan S, Weiss U.

Nature. 2015 Jan 15;517(7534):283. doi: 10.1038/517283a. No abstract available.

PMID:
25592532
8.

Transcription and epigenetics.

Eccleston A, Cesari F, Skipper M.

Nature. 2013 Oct 24;502(7472):461. doi: 10.1038/502461a. No abstract available.

PMID:
24153298
9.

Regulatory RNA.

Eggleston AK, Eccleston A, Marte B, Lupp C.

Nature. 2012 Feb 15;482(7385):321. doi: 10.1038/482321a. No abstract available.

PMID:
22337050
10.

Frontiers in biology.

Eccleston A, Eggleston A, Heemels MT, Marte B, Weiss U.

Nature. 2012 Jan 18;481(7381):277. doi: 10.1038/481277a. No abstract available.

PMID:
22258605
11.

Frontiers in biology.

Eccleston A, Marte B, Nath D, Thomas C.

Nature. 2011 Jan 20;469(7330):313. doi: 10.1038/469313a. No abstract available.

PMID:
21248837
12.

Transcribing the genome.

Eccleston A, Skipper M.

Nature. 2009 Sep 10;461(7261):185. doi: 10.1038/461185a. No abstract available.

PMID:
19741697
13.

Molecular cancer diagnostics.

Marte B, Eccleston A, Nath D.

Nature. 2008 Apr 3;452(7187):547. doi: 10.1038/452547a. No abstract available.

PMID:
18385727
14.

Severe congenital chylothorax treated with octreotide.

Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D.

J Perinatol. 2004 Mar;24(3):200-2.

PMID:
15044932
15.

Developments at trends in cell biology

Eccleston A.

Trends Cell Biol. 2000 Oct;10(10):403. No abstract available.

PMID:
10998590
16.

Chemokine inhibitors for HIV.

Eccleston A.

Nat Biotechnol. 1997 Aug;15(8):709, 710. No abstract available.

PMID:
9255775
17.

Novartis find sparks new GABA drug search.

Eccleston A.

Nat Biotechnol. 1997 May;15(5):403-4. No abstract available.

PMID:
9131606

Supplemental Content

Loading ...
Support Center